This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
May 03, 2019
MIPS INTERIM REPORT JAN – MAR 2019
May 02, 2019
BONESUPPORT HOLDING AB (publ) – Published Q1 2019 Interim report
May 02, 2019
Interim Report Q1 2019
May 01, 2019
Rainier Therapeutics Announces Appointment of Gary Christianson as Chief Technical Officer
May 01, 2019
Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update
April 30, 2019
Pulmonx Announces That HUMANA Has Issued a Positive Coverage Policy for the Zephyr Valve, a Less Invasive Treatment Option for Severe Emphysema (COPD)
April 29, 2019
Nordic Nanovector appoints Fredrik Haavind as Head of Legal and Compliance
April 26, 2019
Oncopeptides Annual Report for 2018
April 25, 2019
Rainier Therapeutics Announces Vofatamab Data Accepted for Presentation at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
April 25, 2019
Strongbridge Biopharma plc Announces Presentation of New Secondary Endpoint Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2019 American Association of Clinical Endocrinologists Ann